SCHEMBL6829075

SCHEMBL6829075

Cc1cc2c(c(C)c1NC(=O)N1CCC(C(=O)N(C)C)C1)c1ccccc1n2C(C)C

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 10/20 0.66
REV1 Q9UBZ9 1/20 0.37
PDK2 Q15119 1/20 0.37
HPGD P15428 1/20 0.36
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
NFKB1 P19838 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
USP2 O75604 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP2D6 P10635 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6826597 0.95 NPY5R (0.64) NPY5RHPGDMAPTHTTKDM4E
SCHEMBL6829275 0.90 NPY5R (0.69) NPY5RREV1NPC1TP53MAPT
SCHEMBL6826986 0.89 NPY5R (0.67) NPY5RREV1PDK2NPC1MAPT
SCHEMBL6824384 0.87 NPY5R (0.59) NPY5RHPGDNPC1TP53MAPT
SCHEMBL6828937 0.85 NPY5R (0.67) NPY5RHPGDMAPTHTTKDM4E
SCHEMBL6823387 0.85 NPY5R (0.61) NPY5RTP53MAPTSMN1; SMN2NPSR1
SCHEMBL6823362 0.84 NPY5R (0.66) NPY5RHPGDMAPTHTTRAB9A
SCHEMBL6826749 0.83 NPY5R (0.65) NPY5RMAPTHTTRAB9AKDM4E
SCHEMBL6826862 0.83 NPY5R (0.61) NPY5RREV1TP53MAPTKMT2A
SCHEMBL6823308 0.81 NPY5R (0.62) NPY5RHPGDNPC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands ASTRAZENECA AB (SE) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands NPY5R, NPY1R, NPY2R NPY5R 1/4885REV1 4218/4885PDK2 1981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.